Lewis Karen

Lewis Karen's trades of Apellis Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-30 2025-01-29
S Sale
364 -0.5%
29.52
USD 10,747 		364 -0.5% 29.52 USD 10,747
2025-01-23 2025-01-22
S Sale
1,751 -2.4%
30.43
USD 53,275 		1,751 -2.4% 30.43 USD 53,275
2025-01-21 2025-01-17
S Sale
1,241 -2.8%
29.96
USD 37,178 		1,241 -2.8% 29.96 USD 37,178
2025-01-14 2025-01-13
S Sale
1,599 -3.4%
28.70
USD 45,895 		1,599 -3.4% 28.70 USD 45,895
2024-01-31 2024-01-30
PS Planned sale
883 -1.9%
65.53
USD 57,863 		883 -1.9% 65.53 USD 57,863
2024-01-31 2024-01-29
S Sale
367 -0.8%
64.14
USD 23,539 		367 -0.8% 64.14 USD 23,539
2024-01-24 2024-01-23
PS Planned sale
4,286 -8.3%
63.69
USD 272,975 		4,286 -8.3% 63.69 USD 272,975
2024-01-23 2024-01-22
S Sale
1,738 -3.2%
65.00
USD 112,963 		1,738 -3.2% 65.00 USD 112,963
2024-01-18 2024-01-17
PS Planned sale
3,276 -5.8%
65.58
USD 214,840 		3,276 -5.8% 65.58 USD 214,840
2024-01-17 2024-01-16
S Sale
1,632 -2.8%
66.81
USD 109,032 		1,632 -2.8% 66.81 USD 109,032
2023-06-02 2023-06-01
PS Planned sale
5,000 -10.8%
86.00
USD 430,000 		5,000 -10.8% 86.00 USD 430,000
2023-04-05 2023-04-03
PS Planned sale
5,000 -10.8%
75.00
USD 375,000 		5,000 -10.8% 75.00 USD 375,000
2023-02-27 2023-02-23
PS Planned sale
1,104 -2.6%
68.76
USD 75,911 		1,104 -2.6% 68.76 USD 75,911
2023-01-31 2023-01-30
PS Planned sale
883 -2.4%
52.76
USD 46,587 		883 -2.4% 52.76 USD 46,587
2023-01-25 2023-01-23
PS Planned sale
2,955 -7.3%
51.58
USD 152,419 		2,955 -7.3% 51.58 USD 152,419
// ... existing code ... // ... rest of the file ...